Abstract:
Homologous disruption of STAT5a and STAT5b expression (STAT5ab experiments, STAT5ab -/-BM was transplanted into non-irradiated W/W v hosts. In these mice, C57BL/6 STAT5ab -/-BM cells were 10-fold more defective in long-term engraftment than control wild-type BM cells and HW80 STAT5ab -/-BM cells were 5-to 10-fold more defective than C57BL/6 STAT5ab -/-BM cells. Therefore, we conclude that STAT5 plays a critical role during steady-state HSC engraftment and a chromosome 7 modifier locus regulates this activity.
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Introduction:
The bone marrow (BM) niche plays a direct role in supporting hematopoietic engraftment and long-term hematopoiesis.
Myeloablative conditioning is required for high levels of hematopoietic chimerism following injection with BM cells, although this is cell dose dependent.
Repeated injections with cumulative doses of 2 x 10 8 cells in a wild-type Balb/c mouse model have been successful at obtaining significant chimerism in adult recipients 1 , indicating that this dependence on irradiation can be overcome. Further studies in a non-ablated newborn injection model showed that repeated intravenous (i.v.) injections with a cumulative dose of 3 x 10 7 adult BM cells could engraft mucopolysaccharidosis type VII (MPS VII) neonates long-term 2 . The concept that engraftment of donor HSCs is based on competition 3 , not space, is also supported by recent observations using either local irradiation 4 or intra-femoral injection 5 of donor BM cells.
The reasons for enhanced engraftment following irradiation likely involve multiple factors including; changes in adhesion receptor expression of the host, release of bioactive cytokines and proteases, or simply creating a non-competitive host HSC pool that is easily replaced.
Overcoming these obstacles to HSC engraftment is a central issue in the fields of cell and gene therapy for hematologic disorders.
Although myeloablative conditioning is generally required for donor engraftment of BM HSCs, some genetically altered mouse models are very receptive to donor engraftment without the need for myeloablative conditioning. Classic examples of this are mice with mutations at the W locus of which the WBB6F 1 W/W v mutant is viable but has major defects in melanocytes, male germ cells, and erythroid progenitors 6 . Furthermore, the HSCs in these mice are non-competitive with wild-type HSCs even in situations when they are already occupying the HSC niche and no
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Genomic studies by others have also identified a 10 centimorgan region on chromosome 11 that is important for hematopoietic stem/progenitor cycling activity and repopulating function 12 . This locus contains both the STAT5a and STAT5b genes, which are more highly expressed in the more rapidly dividing DBA/2 mouse strain compared with C57BL/6. Therefore, STAT5 may be a mediator of HSC proliferation and consequently regulate HSC interaction with the BM niche.
STAT5ab
-/-mice are severely defective in the long-term competitive repopulating activity 13;14 , a phenotype that is associated with reduced sensitivity to the S-phase specific drug 5-fluorouracil 15 . These earlier studies also demonstrated that by generation of BM chimeras following injection of STAT5ab -/-BM into lethally-irradiated hosts, the cells were intrinsically capable of engraftment without a viable competitor. However, these cells were extremely defective in the ability to maintain hematopoiesis when a wild-type competitor was injected 16
weeks later, suggesting a specific role for STAT5 activation during steady-state hematopoiesis 15 .
For personal use only. Logan UT) and counted using a hemacytometer. Colony-forming unit in culture (CFU-C) assays were performed by plating 1 x 10 5 BM cells into a 3 ml aliquot of methylcellulose medium containing growth factor combinations that included either 10 ng/ml recombinant murine GM-CSF alone or a cocktail of 20 ng/ml recombinant murine IL-3, 50 ng/ml recombinant human IL-6, 50 ng/ml recombinant murine SCF, and 3 units/ml recombinant human erythropoietin (EPO).
On day 7 of culture, BM colonies of greater than 50 cells were counted. Table 1) . HW80 STAT5ab -/-mice had the characteristic decrease in absolute lymphocyte count and had a mild anemia. BM cells were then collected from the mice and the number of colony-forming unit in culture (CFU-C) was determined as described previously on the C57BL/6 background. The results of these studies were similar to studies using C57BL/6 background mice 18 , where STAT5ab -/-CFU-C frequency was not significantly different from wild-type CFU-C frequency (P>0.4).
To further define the ability of C57BL/6 and HW80 STAT5ab -/-HSCs to engraft into lethallyirradiated hosts, we transplanted BM from these mice into congenic Ly-5.1 recipients and measured Ly-5.2 engraftment ( 
HSCs from newborn STAT5ab -/-mice are replaced by wild-type donor HSCs without prior irradiation
Although adult STAT5ab -/-mice are born at normal numbers, they have a very poor survival rate up to weaning age. Retrospective analysis over 1-year for genotyping results showed that from 464 weaned C57BL/6 heterozygote cross progeny 39% +/+, 55% +/-, and 6% -/-were obtained compared with 443 weaned HW80 heterozygote cross progeny that were 32% +/+, 58% +/-, and 10% -/-. Chi square analysis showed that both backgrounds yielded significantly fewer STAT5ab -/-mice than the expected Mendelian ratio of 25% (P<0.001) but the HW80 background supported an improvement in peri-natal survival relative to C57BL/6 (P=0.02). Fig. 2A shows a
Western blot analysis on brain tissue which is rich in STAT5 expression. This blot demonstrates the reduction in STAT5 expression in heterozygote mice and the absence of STAT5 expression because at this time the mothers could be confirmed to be taking care of the pups and overall yield of surviving pups was improved. GFP transgenic BM was injected into newborn STAT5ab -/-mice using an approach that we previously described in the context of a gene therapy model for JAK3-deficient severe combined immunodeficiency 23 ( Fig. 2A) .
Following injection of 2-3 day old pups with adult BM cells, the pups were kept with their mothers until weaning age. At weaning, they were then analyzed for GFP expression by flow cytometry. As expected, the levels of GFP expression were extremely low to undetectable in total blood leukocytes of wild-type recipients. also by Southern blot analysis of BM and spleen tissues (bottom panels) from mice that were euthanized 20 weeks post transplant (Fig. 4) . The levels of STAT5ab -/-engraftment obtained in our studies were higher than those reported for MPS VII newborn recipients (~14%) 2 . This was observed despite the use of suboptimal injection conditions in these studies. A single i.p. dose was used in our study whereas studies in MPS VII mice used three i.v. injections with a cumulative injection of 3-fold more donor BM cells. The lack of a selective advantage for HSCs in the MPS VII mice is likely to account for this difference. Additionally, it is important to note that the -actin/GFP transgene is not active in all donor BM cells, so our GFP positive levels may underestimate true engraftment levels. In contrast to the MPS VII mouse, the PU.1 mutant mouse has competitive repopulating defects at the HSC level and can also be rescued by neonatal BM transplant 34;35 . Engraftment levels in PU.1 -/-spleen were 90% donor-derived up to 4 months after transplant 35 , indicating that when a selective advantage is present, high levels of HSC engraftment can be achieved in hematopoietic tissues. Unlike reported for PU.1 -/-mice, we found that perinatal survival of STAT5ab -/-mice was not improved following BM injection. However STAT5ab -/-mice that survived had complete restoration of normal hematology. This is consistent with demonstration that irradiated
STAT5ab
-/-mice have a normal stromal microenvironment that can support wild-type BM grafts 36 .
The previous finding that either congenic STAT5ab -/-BM could compete equally for engraftment into irradiated hosts 18 , provides an interesting contrast that highlights a unique function for STAT5. The equal engraftment in irradiated hosts indicates that the functional HSC activity is not changed, yet the ability to compete with a defective host for engraftment during steady-state hematopoiesis was specifically and significantly affected in these studies. It is possible that the STAT5-deficient phenotype described in this study involves deficiency in adhesion, migration, or homing at the HSC level. Engraftment of HSCs varies according to transit through the cell cycle 37 and a linkage between proliferation and adhesion was also recently described for Rac1/Rac2 mutant mice 38 . It is known that DBA/2 mice age quickly and have high hematopoietic cell turnover. Interestingly, this is linked to a QTL for chromosome 11 where STAT5a and STAT5b expression is higher than in C57BL/6 mice 12 . Also, fetal liver HSCs which are actively cycling express more STAT5 than adult HSCs [39] [40] [41] . Therefore, the profound defects reported in this study may explain some of the HSC repopulating differences between mouse strains and during ontogeny.
Analysis of the chromosome 7 modifier locus revealed greater than 200 genes. A survey of these genes for genes that have known roles in hematopoiesis results in only a small subset since most in this region were non-hematopoietic or olfactory genes. gab2, pak1, fes, and wnt11 are candidate genes in this region that might play a role in hematopoiesis given their direct involvement in cytokine and integrin signaling. Further genetic studies will be needed to
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identify the modifier gene within this locus and to determine the mechanism by which it affects STAT5 function. Although attempts to identify modifier genes have been notoriously difficult, in our model we expect that this could be achieved. C57BL/6 and HW80 mice differ in a relatively small region, with easily identifiable albino coat color/pink eye and hemoglobin markers. Thus there would be no need to start out from the entire Balb/c genome. The genetic dissection of signaling pathways regulating important biological properties of HSCs offers considerable promise. Future studies using these models may elucidate molecular targets for novel approaches to enhance HSC homing and engraftment in the absence of myeloablation and may uncover cross-talk among signaling pathways that cooperate with STAT5 in this previously unrecognized function. 4 to 8 week old STAT5ab -/-(N=4) and littermate wild-type (N=4) mice were bled and analyzed for peripheral blood hematology. These mice were also euthanized and the BM cells were harvested and plated in methylcellulose medium to assay for the CFU-C frequency in response to either granulocyte/macrophage colony-stimulating factor (GM-CSF) or the cytokine cocktail of interleukin (IL)-3, IL-6, stem cell factor (SCF), and erythropoietin (EPO). These differences are of no consequence for transplant into lethally-irradiated recipients and thus can serve as a useful marker for donor engraftment. However, the role of other genes within this chromosome 7 fragment has not been characterized in terms of HSC biology. 
